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Summary: Phospholamban, a phosphorylatable protein of the cardiac sarcoplasmic reticulum, has been
esümated by a semi-quantitative immunoassay. It can be determinated in purified membrane preparations
äs well äs in crude fractions of cardiac muscle membranes, regardless of the phosphorylation state of the
phosphoprotein. The content of phospholamban in mammalian heart muscle membrane vesicles correlates
with the activity of the calcium/magnesium-dependent ATPase with the exception of the oxalate-loaded
membrane preparations. This observation indicates that phospholamban and the calcium transporting enzyme
are localized at different sites in cardiac sarcoplasmic reticulum.
Introduction
In 1972 Wollenberger (1) reported the presence of a
phosphorylatable protein in a cardiac microsomal
fraction. It was subsequently thoroughly investigated
and named „phospholamban" because it is an excel-
lent Substrate for cyclic AMP-dependent protein ki-
nase1) and, äs reported later, also for a calcium/
calmodulin-dependent protein kinase (for review see
I.e. (2)). This protein phosphorylation is correlated
with an alteration of the calcium transport activities
of the heart sarcoplasmic reticulum. Phospholamban
is believed to be a regulator protein of the calcium
transport ATPase of this particular membrane System
(3), but the mechanism of this interaction is not yet
fully unterstood.
Phospholamban seems to be a heart-specific proteo-
lipid. Different groups have described phospholam-
ban Or a phospholamban-like protein äs a constitu-
tent of the sarcoplasmic reticulum and also of the
sarcolemma of heart muscle cells (4, 5). However, the
determination of the phospholamban content of these
membrane Systems is rather difficult, in äs much äs
Enzymes
Ca, Mg-dependent ATPase: EC 3.6.1.3
cyclic AMP-dependent protein kinase: EC 2.7.1.37
the proteolipid is weakly or not at all stainable in
electrophoretic gels. Furthermore, protein determina-
tions have given widely differing values for phospho-
lamban, depending on the method used (6).
Based on its electrophoretically determined molecular
weight and on the assumed l : l molar ratio of enzym-
atically incorporated 32P-labelled phosphoryl groups
per polypeptide chain, quantification of phospholam-
ban ranges from about l to 6 per cent by weight of the
total membrane protein of the cardiac sarcoplasmic
reticulum (7).
The development of an immunochemical assay
should overcome some of these difficulties.
The aim of this paper is to describe the principle of
a semi-quantitative enzyme immunoassay for phos-
pholamban which was recently employed in a com-
parative study of the phorphorylation state of phos-
pholamban in canine heart (8).
Materials and Methods
Horseradish peroxidasc (AWD Dresden) was purified on con-
canavalin A-Sepharosc. Goat anti-rabbit-IgG antibodies (SlflN
Berlin) were enriched by afllnity chromatography on rabbit
immunoglobulin-Sepharose. [ -" ] (spec. radioactivity ISO
TBq/mmol) was from ZfK Rossendorf (GDR). Nitroccllulosc
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sheets were from Serva (Heidelberg), and polystyrene microtitre
plates from VEB Polyplast Halberstadt (GDR). Freund** adju-
vant was from Ifl Dessau (GDR), and 3,3',4,4'-tetraamino-
diphenylether was a gift from Dr. Ziebarth (ZIK Berlin).
Phospholamban was purified to electrophoretic homogeneity
from porcine cardiac sarcoplasmic reticulum s described in
1. c. (9). Heart sarcoplasmic reticulum was prepared according
to Harigaya & Schw rtz (10) with slight modifications. Highly
purified heart sarcolemma was a gift of Dr. Vetter and was
prepared s specified in I.e. (11). Skeletal muscle sarcoplasmic
reticulum from porcine diaphragm was prepared following the
method given by I.e. (12). Crude membrane ffactions of dif-
ferent muscle types were isolated s described in 1. c. (8). Puri-
fied cardiac sarcoplasmic reticulum („oxalate SR") was pre-
pared s described in I.e. (13).
Induc t ion of antibodies
Antibodies against purified phospholamban were produced in
rabbits. Typically, a first immunization was performed by injec-
tion of 250 μg of the purified protein in complete FreuncFs
adjuvant/saline (l + l by volume) near to the popliteal lymph
node. Booster injections were made six weeks later (200 μg in
incomplete FreimcFs adjuvant/saline) and two weeks after the
first booster by i. v. injection of a Suspension of 170 μg of
phospholamban in saline. The development of antibody pro-
duction was monitored by the described immunoassay.
Enzyme-linked immunoassay
For the development of the enzyme-linked immunoassay we
followed the description of Douillard & Hoffman (14). Gardiac
sarcoplasmic reticulum, other membrane preparations, and pu-
rified phospholamban were diluted in the binding buffer (10
mmol/1 sodium bicarbonate, pH 9.6) to a protein concentration
of 25 mg/1. A serial dilution of this solution (200 μΐ) were
pipetted into the wells of a microtitre plate. After incubation
overnight at 4 °C the plate was rinsed three times with phos-
phate-bufTered saline, pH 7.4, l g/l gelatine, 0.5 g/l Tween 20.
This was followed by the incubation of the bound protein with
an appropriate dilution of the antiserum (usually l ; 1500) or
of normal control rabbit serum in phosphate-buffered saline,
pH 7.4, l g/l geiatine, 0.5 g/l Tween 20 for two hours at room
temperature using a shaker. The unbound serum was washed
out with phosphate-buffered saline, pH 7.4, l g/l gelatine, 0.5
g/l Tween 20 and was replaced by 200 μΐ of a l : 2000 dilution
of the horseradish peroxidase-immunoglobulin conjugate in
phosphate-buffered saline, pH 7.4, l g/l gelatine, 0.5 g/l Tween
20, and the plates were incubated for further two hours. The
wells were rinsed again three times with phosphate-buffered
saline, pH 7.4, l g/l gelatine, 0.5 g/l Tween 20.
The peroxidase reaction was started by adding 200 μΐ of the
Substrate buffer (10 mg o-phenylenediamine and 10 μΐ 300 g/kg
H2O2 per 100 ml of 51.5 mmol/1 disodium hydrogen phosphate,
33.8 mmol/1 citric acid, pH 5.5). The reaction was stopped 15
min later by addition of 60 μΐ of 6 mol/1 sulphuric acid. The
absorbance was measured in a multichannel spectrophotometer
at 492 nm within 30 minutes.
Electroblotting
The specificity of the obtained antisera was checked by immu-
noblotting. Membrane proteins were separated in sodium do-
decylsulphate-containing polyacrylamide gels (see below) then
transfered onto nitrocellulose sheets by a modified version of
the method of Khyse-Anderson (15). This modification eonsisted
of the use of an additional sheet of filter paper soaked with 25
mmol/1 Tris-base, 40 mmol/l ε-aminocaproic acid, and 0.5 g/l
sodium dodecylsulphate at the cathodic site of the electrophore-
sis gel. Transfer was performed for 1.5 h at room temperature
with 0.8 mA constant current per cm2 gel area.
After transfer the remaining active sites of the nitrocellulose
were blocked in phosphate-buffered saline, pH 7.4, l g/l gela-
tine, 0.5 g/l Tween 20 for 10 minutes. Incubation with the
anti-phospholamban antiserum (dilution l : 2000 in phosphate-
buffered saline, pH 7.4, l g/l gelatine, 0.5 g/l Tween 20 was
perfprmed at 4 °C overnight, followed rby three washes in phos-
phate-buffered saline, pH 7.4, l g/l gelatine, 0.5 g/l Tween 20,
incubation with a l : 2000 dilution of the peroxidase conjugate
in phosphate-buffered saline, pH 7.4, l g/l gelatine, 0.5 g/l
Tween 20, and the subseqoent enzymatic reaction in phosphate-
buffered saline with 3,3%4,4^etraaminq diphenylether and
H2O2 s Substrates.
Miscellaneous methods
Phosphorylation experiments in the presence of [γ*32Ρ]ΑΤΡ and
the catalytic subunit of the cyclic AMP-dependent protein
kinase were perfonned s described in Lc. (9). The reaction
was terminated either by a SQ^fold dilution of the reaction
mixture with ice-cold stop buffer (50 mmol/1 KC1, 5 mmol/1
dithiothreitol, 10 mmol/1 histidine, pH 6.8), by mixing with an
equal volume of 150 g/l trichloroacetic acid, or by adding the
s me volume of a solution of 150 g/l of sulphosalicylic acid.
The mixtures were centrifuged and the pellets were dissolved
in the electrophoresis sample buffer (50 mmol/1 Tris HC1, pH
6.8, 50 g/l sodium dodecylsulphate, 50 ml/l 2-mercaptoethanol)
without further heating.
Sodium dodecylsulphate gel electrophoresis was run in the
Laemmli System (16) with T = 12.8% and C = 5.0%.
Autoradiographs were prepared using ORWO HS 11 X-ray
films at ^78°C. The autoradiographs and the blots were
scanned on a Shimadzu CS-910 scannet (wavelength for the
reaction product of the peroxidase reactipn: 485 njm, for autor ^
diographs: 495 nm).
The activity of the calcium/magnesium-dependent ATPase1)
was determined by a coupled optical assay according to I.e.
(17). The conditions for the assay were (final concentrations,
mmol/1): 80 histidine, pH 7.0, 37 °C, 100 KC1, 5 NaN3,4 MgCl2,
2 ATP, l phosphoenolpyruvate, 0.2 NADH, 0.1 digitoxigenin,
10 mg/1 pyruvate kinase, 10 mg/1 lactate dehydrogenase, 1.5
mg/1 ionophore A 23187 in the presence or absence of 50 μιηοΐ/ΐ
CaCl2. The reaction was started by addition of the appropriate
membrane vesicles (5 to 20 mg/1 protein).
Protein was estimated by Lowry*$ method (18) with ovalbumin
s Standard.
Results
Below 5 t 10 μ§ protein per well (25 to 50 mg/1; 3
to 6 μg/cm2 well surface) the q antity of protein
was correlated with the absorbance of the peroxidase
reaction product, i. e. within the binding capacity of
the polystyrene microtitre plates. This correlation
was verified for crude and purified porcine cardiac
sarcoplasmic reticulum (fig. 1). A c rrelation also
exists for the crude membrane fractions from rat and
rabbit heart (fig. 1) and for purified phospholamban.
The specificity of the obtained antisera is shown
by the electrpblot of electrophoretically separated
membrane proteins. Phospholamban was dedected
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Fig, 1. Dose-response curve of the phospholamban enzymc
immunoassay. The wells were coated with cardiac mera-
branc preparations, followcd by an incubation with
antiphospholamban antisera (rabbit) and horscradish
peroxidasc-anti-(rabbit-immunoglobulin)-IgG (goal)
conjugatc.
ο —α sarcoplasmic reticulum (pig); D — D crudc raem-
branes (pig); Δ — Δ crudc mcmbrancs (rabbit); χ — χ
crude mcmbranes (rat).













Fig. 2. Electropherogram, immunoblot, and autoradiogram of
different membrane preparations.




a — cardiac sarcoplasmic reticulum (pig);
b - the same s in a, boiled for 3 min prior to the
electrophoresis;
c — eardiac sarcolemma (pig);
d — skeletal sarcoplasmic reticulum (diaphragm, pig).
* — high molecular weight form of phospholamban (Mr
.. =27000);
** — low molecular weight form of phospholamban.
by irnmunobl tting and by autoradiography. The im-
inunostain of the electroblots and autoradiographs
of the blots were compared with autoradiographs
of 32P-labeled sarcoplasmic reticmhim, separated by
sodium dodecylsulphate polyacrylamide gel electro-
phoresis (fig. 2).
The phospholamban-bound 32P-radioactivity of the
Mr = 27000 moiety (Fig. l, lane 3a,c and 2a,c,
asterisk) and of the MT = 8000 band and the immu-
nostain were located in the same way.
Boiling of the vesicles of sarcoplasmic reticulum in
electrophoresis sample buffer prior to electrophoresis
shifted the high molecular weight form to the
MT = 8000 band in the immunostain s well s in the
autoradiograph (fig. 2, lanes 2b and 3b). This low
molecular weight form of phospholamban (indicated
by two asterisks in fig. 2) is clearly different from the
A/r = 15000 phosphoprotein of the cardiac sarco-
lemma, s indicated by its position in autoradi-
ographs (fig. 2, lanes 3c and 2c). There was no
immunoreactivity on electroblots using skeletal mus-
cle sarcoplasmic reticulum (fig. 2, lanes d).
The obtained polyspecific antibodies recognized sub-
types of high molecular weight phospholamban both
in the phosphorylated and in the non-phosphorylated
state. Figure 3 shows the densitograms of immuno-
blots *
a) of 32P-labeled, cyclic AMP-dependent phosphoryl-
ated phospholamban,
Fig. 3. Autoradiogram and densitogram of hnmunoblots.
1 — autoradiogram,
2 - densitogram of the immunoblot (arbitrary units).
a - phosphorylated, [32P]labeled sarcoplasmic retic-
ulum;
b - the same s in a, treated with phosphatase S;
c — unphosphorylated sarcoplasmic reticulum.
Arrow and dotted line indicatc the high molecular
weight form of phospholamban (A/r ca. 27000).
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b) of the same preparation after phosphatase S treat-
ment (only the protein-bound 32P-phosphate
groups were removed, whereas the 32P-label of the
phospholipids at the dye front of the electropher-
ogram was not influenced), and
c) of untreated vesicles of sarcoplasmic reticulum.
The arrow and the dotted line indicate the average
value for the high molecular weight form of phos-
pholamban (Μτ = 27 000) and at least three different
isoforms of the proteolipid. The different ratio of
the peak height of these three subtypes could not
significantly be correlated with a distinct Status of
phosphorylation.
Furthermore, the shapes of phospholamban bands on
electropherograms differ, depending on the procedure
by which the phosphorylation reaction was termi-
nated. As shown in figure 4, the autoradiograph and
especially the immunoblot gave different results after
precipitation of membrane vesicles by
i) ice-cold trichloroacetic acid (fig. 4, lanes a),
ii) ice-cold sulphosalicylic acid (fig. 4, lanes b), or
iii) termination of the phosphorylation reaction by
dilution, followed by high spin centrifugation.
The shape of the Μτ = 27 000 band was relatively
constant, but the low molecular weight form smeared
over a large area in i) and to a less extent in ii). The
pictures obtained after dilution/centrifugation were
most similar to those of purified phospholamban (fig.
4, lanes 2c, 3c and 2d, 3d). The peak height ratio
of the Mr = 27000 to the Mr = 8000 to 12000 forms
increased in the order a) to c) and the ratio of c) was
also closest to that of purified phospholamban (fig.
4, lanes d). In contrast, the Coomassie stain (fig. 4,
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Fig. 4. Influence of the termination procedure of the phosphor-
ylation reaction on the autoradiogram and immunoblot
pattern.
1 — electropherogram (Coomassie brillant bl e R250
staining),
2 — [3?P]autoradiogram,
3 — densitogram of the immunoblot (arbitrary units).
a — precipitation by trichloroacetic acid;
b — precipitation by suljphos licyclic acid;
c — dilution and high speed centrifugation;
d — purified phospholamban.
A — high molecular weight form of phospholamban;
B — low molecular weight form.
For details see text.
Tab. 1. Relative content of phospholamban and calchim-dependent ATPase activity in different membrane preparations.
Mean ± S.D., number of independent estimations in parenthesis.














SR = sarcoplasmic reticulum,
SL = s rcolemma
100.0
106.3 ± 5.1 (5)
55.4 ± 6.6 (6)
17.2 + 3.5 (6)
10.0 (1)
15.8 ± 1.5 (6)
15.8 + 0.6 (6)
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The speciflty of the antisera and the linearity of the
solid-phase immunoassay provided an opportunity to
determine the phospholamban content of membrane
preparations from different sources.
As presented in table l, the relative content2) of
phospholamban of different membrane samples (sa-
croplasmic reticulum, „oxalate SR" sarcoplasmic re-
ticulum, sarcolenima, crude muscle membrane frac-
tions) and of several species (dog, man, pig, rabbit,
rat) was estimated and correlated with the calcium/
magnesium-dependent ATPase activity. In all cases,
the phospholamban content corresponded to the en-
zyme activity, with the exception of the ATPase-
enriched „oxalate SR" which showed a ratio of phos-
pholamban content to enzyme activity of only one
third.
Discussion
Phospholamban has been investigated for the last l5
years, but both its exact molecular structure and its
function are still a matter of discussion. Determina-
tion of its molecular weight by sodium dodecylsul-
phate polyacrylamide gel electrophoresis gave values
from Mr = 20000-28000 (2, 6, 19) for the high
molecular weight form. Using the partial amino acid
sequence published recently by Simmerman et al. (19)
a MT of about 5000 was calculated for the monomer
and a pentamer is favored in their paper äs the
functional structure of phospholamban. The molecu-
lar weight calculated from the complete cDNA-
derived amino acid sequence äs presented by 1. c. (20)
is 6080.
Phosphorylation of phospholamban by protein
kinases results in an increase in the apparent molecu-
lar weight (21). The decrease in the relative electro-
phoretic möbility in the sodium dodecylsulphate
polyacrylamide gel electrophoresis niay be due to a
lower content of sodium dodecylsulphate per mole-
cule of the phosphorylated protein. This nonstoichio-
metric relation between phospholamban and the de-
tergent may explaiii the unüsual pattern of phospho-
lamban in electropherograms in dependeiice on the
anion (acid) used for the termination of the phos-
phorylation reaction (cf. fig. 4).
As demonstrated in I.e. (19), each subunit of phos-
pholamban has one phosphorylatable site for the
2) The relative content of phospholamban is defined äs the
absorbance of the horseradish peroxidase-immunoglöbulin
conjugäte reaction product <at 492 nm per mg of membrane
protein related to the absorbance per mg of a standardized
porcine cardiac sarcoplasmic reticulum preparation.
cyclic AMP-dependent protein kinase and one for
the calcium/calmodulin-dependent protein kinase(s).
The quantification of phospholamban by measuring
the in vitro incorporation of 32P-phosphate may be
questionable, because a possible positive or negative
cooperativity between the subunits during phosphor-
ylation äs well äs the in vivo phosphorylation state of
the protein are unknown, and dephosphorylation by
phosphatase S is accompanied by a loss of detectable
phospholamban (8). Hitherto direct evidence for a
steric hindrance of both phosphorylation sites is lack-
ing, but this may arise if the phosphorylatable amino
acids are neighbours (19).
For the absolute determination of the phospholam-
ban content of a membrane preparation the exact
determination of a purified preparation is necessary.
The discrepency between the protein determination
by Lowry's method and by dye binding protein assays
(6) can be explained by the relative low content of
aromatic amino acids in the molecule (19, 20). To
overcome this problem we developed the described
relative immunoassay which does not give the abso-
lute value of the phospholamban content but makes
it possible to compare the relative amounts of phos-
pholamban in membrane preparations of different
physiological states.
A remarkable observation in the present study was
the discrepancy between the relative phospholamban
content and the calcium/magnesium-dependent ATP-
ase activity in oxalate-loaded sarcoplasmic reticulum
vesicles (tab. 1). Whereas in all other membrane pre-
parations the phospholamban content and the en-
zyme activity were in the same order of magnitude,
in oxalate-loaded vesicles the amount of phospholam-
ban was only a third with respect to the enzyme
activity. This phenomenon can be explained by an
enrichment of the calcium transporting enzyme dur-
ing these specific preparation conditions and points
to a different localization of phospholamban and
calcium/magnesium-dependent ATPase within the
sarcoplasmic membrane network.
The observed content of phospholamban in sarcolem-
mal preparations does not provide conclusive evi-
dence concerning the presence of phospholamban in
cardiac sarcolemma. So far, there is no further evi-
dence that a phospholamban-like sarcolemmal
proteolipid („calciductin") exists in cardiac cells (cf.
I.e. (22), which could be immunochemically similar
to phospholamban. Attemps the localize phospho-
lamban ultrastructurally, however, favour its presence
in the intracellular network (W. Schulze & M.
Holtzhauer, unpublished).
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The polyclonal anti-phospholainban antiserum
showed no species differences (fig. l, tab. 1). The
possibility of estimating phospholamban in crude
membrane fractions of heart muscle opens the pros-
pect of a semi-quantitative determination of
pholamban in biopsies of different animals. It is
hoped to achieve this aim in a follow-up investigation.
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